Literature DB >> 7600175

Data analysis for dynamic contrast-enhanced MRI-based cerebral perfusion measurements: correcting for changing cortical CSF volumes.

J F Emerson1, P C Chen, W R Shankle, R J Haier, O Nalcioglu.   

Abstract

The time evolution of the histogram (number of pixels versus signal intensity) is used to calculate delta R2 parameters from dynamic contrast-enhanced magnetic resonance (MR) imaging of the brain. This method partially corrects for partial volume effects and is an improvement over the approach using the signal intensity as a function of time when confounding factors such as changing cortical cerebrospinal fluid volumes are involved. The maximum value for delta R2 is found to correlate with relative cerebral blood flow as assessed by xenon inhalation and can be used to discriminate between vascular dementia and healthy volunteers. With this method, the normal range for delta R2 values is found to be the same for both young (19-40 years old) and elderly (65-85 years old) healthy volunteers.

Entities:  

Mesh:

Year:  1995        PMID: 7600175     DOI: 10.1007/BF02426399

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  10 in total

1.  A software system for interactive and quantitative visualization of multidimensional biomedical images.

Authors:  R A Robb; D P Hanson
Journal:  Australas Phys Eng Sci Med       Date:  1991-03       Impact factor: 1.430

2.  Cortical CSF volume fluctuations by MRI in brain aging, dementia and hydrocephalus.

Authors:  J F Emerson; P C Chen; W R Shankle; F S Greensite; E L Foltz; I T Lott; O Nalcioglu
Journal:  Neuroreport       Date:  1994-09-08       Impact factor: 1.837

3.  Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging.

Authors:  J C Gore; S Majumdar
Journal:  Magn Reson Med       Date:  1990-05       Impact factor: 4.668

4.  Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects.

Authors:  A Villringer; B R Rosen; J W Belliveau; J L Ackerman; R B Lauffer; R B Buxton; Y S Chao; V J Wedeen; T J Brady
Journal:  Magn Reson Med       Date:  1988-02       Impact factor: 4.668

5.  Perfusion imaging with NMR contrast agents.

Authors:  B R Rosen; J W Belliveau; J M Vevea; T J Brady
Journal:  Magn Reson Med       Date:  1990-05       Impact factor: 4.668

6.  Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA).

Authors:  S H Koenig; M Spiller; R D Brown; G L Wolf
Journal:  Magn Reson Med       Date:  1986-10       Impact factor: 4.668

7.  The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases.

Authors:  M C Tierney; R H Fisher; A J Lewis; M L Zorzitto; W G Snow; D W Reid; P Nieuwstraten
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

8.  Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T.

Authors:  R R Edelman; H P Mattle; D J Atkinson; T Hill; J P Finn; C Mayman; M Ronthal; H M Hoogewoud; J Kleefield
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

9.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers.

Authors:  H C Chui; J I Victoroff; D Margolin; W Jagust; R Shankle; R Katzman
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

10.  Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA.

Authors:  G Strich; P L Hagan; K H Gerber; R A Slutsky
Journal:  Radiology       Date:  1985-03       Impact factor: 11.105

  10 in total
  1 in total

1.  The effects of healthy aging on intracerebral blood vessels visualized by magnetic resonance angiography.

Authors:  Elizabeth Bullitt; Donglin Zeng; Benedicte Mortamet; Arpita Ghosh; Stephen R Aylward; Weili Lin; Bonita L Marks; Keith Smith
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.